Cargando…

Characterization of ductal and lobular breast carcinomas using novel prolactin receptor isoform specific antibodies

BACKGROUND: Prolactin is a polypeptide hormone responsible for proliferation and differentiation of the mammary gland. More recently, prolactin's role in mammary carcinogenesis has been studied with greater interest. Studies from our laboratory and from others have demonstrated that three speci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ginsburg, Erika, Alexander, Stefanie, Lieber, Sarah, Tarplin, Sarah, Jenkins, Luwanda, Pang, Linda, Heger, Christopher D, Goldsmith, Paul, Vonderhaar, Barbara K
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3009681/ https://www.ncbi.nlm.nih.gov/pubmed/21144038 http://dx.doi.org/10.1186/1471-2407-10-678

Ejemplares similares

Mixed ductal‐lobular carcinomas: evidence for progression from ductal to lobular morphology
por: McCart Reed, Amy E, et al.
Publicado: (2018)

The Clonal Relationship Between the Ductal and Lobular Components of Mixed Ductal-Lobular Carcinomas Suggested a Ductal Origin in Most Tumors
por: Pérez-Mies, Belén, et al.
Publicado: (2022)

Hornerin, an S100 family protein, is functional in breast cells and aberrantly expressed in breast cancer
por: Fleming, Jodie M, et al.
Publicado: (2012)

Spontaneous apoptosis of circulating T-lymphocytes and its correlation to their prolactin receptor expression and prolactin plasma levels in patients with breast cancer
por: Bauernhofer, T, et al.
Publicado: (2001)

Inflammatory infiltrate in invasive lobular and ductal carcinoma of the breast.
por: Lee, A. H., et al.
Publicado: (1996)

Phylogenetic analysis of combined lobular and ductal carcinoma of the breast
por: Kobayashi, Hiroko, et al.
Publicado: (2021)

Prolactin Receptor (PRLR) Isoform Expression in the Murine Oviduct
por: Radecki, Kelly C, et al.
Publicado: (2021)

Pleomorphic lobular carcinoma: is it more similar to a classic lobular cancer or to a high-grade ductal cancer?
por: Costarelli, Leopoldo, et al.
Publicado: (2017)

Histopathological and clonal study of combined lobular and ductal carcinoma of the breast
por: Tazaki, Eri, et al.
Publicado: (2013)

Granulomatous lobular mastitis associated with ductal carcinoma in situ of the breast
por: Oddó, David, et al.
Publicado: (2019)

PB.04: MRI In lobular and mixed lobular/ductal carcinomas: can we preselect cases based on imaging appearance?
por: Hoosein, MM, et al.
Publicado: (2013)

Collective invasion in ductal and lobular breast cancer associates with distant metastasis
por: Khalil, Antoine A., et al.
Publicado: (2017)

Prognosis and Early Diagnosis of Ductal and Lobular Type in Breast Cancer Patient
por: EHTEMAM, Houriyeh, et al.
Publicado: (2017)

Mammographic density, lobular involution, and risk of breast cancer
por: Ginsburg, O M, et al.
Publicado: (2008)

Progesterone Receptor Activates Msx2 Expression by Downregulating TNAP/Akp2 and Activating the Bmp Pathway in EpH4 Mouse Mammary Epithelial Cells
por: Fleming, Jodie M., et al.
Publicado: (2012)

A comparison of the clinical metastatic patterns of invasive lobular and ductal carcinomas of the breast.
por: Dixon, A. R., et al.
Publicado: (1991)

The clinical behavior of mixed ductal/lobular carcinoma of the breast: a clinicopathologic analysis
por: Suryadevara, Aparna, et al.
Publicado: (2010)

Isoform-specific knockdown of long and intermediate prolactin receptors interferes with evolution of B-cell neoplasms
por: Taghi Khani, Adeleh, et al.
Publicado: (2023)

Prolactin signaling through the short isoform of the mouse prolactin receptor regulates DNA binding of specific transcription factors, often with opposite effects in different reproductive issues
por: Devi, Y Sangeeta, et al.
Publicado: (2009)

Role of prolactin receptor and CD25 in protection of circulating T lymphocytes from apoptosis in patients with breast cancer
por: Bauernhofer, T, et al.
Publicado: (2003)

Short prolactin isoforms are expressed in photoreceptors of canine retinas undergoing retinal degeneration
por: Sudharsan, Raghavi, et al.
Publicado: (2021)

Risk factors for ductal and lobular breast cancer: results from the nurses' health study
por: Kotsopoulos, Joanne, et al.
Publicado: (2010)

Immunological subtypes in breast cancer are prognostic for invasive ductal but not for invasive lobular breast carcinoma
por: Engels, C C, et al.
Publicado: (2014)

Comparison of Syndecan-1 Immunohistochemical Expression in Lobular and Ductal Breast Carcinoma with Nodal Metastases
por: Miše, Ivana, et al.
Publicado: (2018)

Breast MRI increases the number of mastectomies for ductal cancers, but decreases them for lobular cancers
por: Lobbes, Marc B.I., et al.
Publicado: (2017)

High rates of breast conservation for large ductal and lobular invasive carcinomas combining multimodality strategies
por: Bollet, M A, et al.
Publicado: (2008)

Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis
por: Turashvili, Gulisa, et al.
Publicado: (2007)

Relevance of systems biological approach in the differential diagnosis of invasive lobular carcinoma & invasive ductal carcinoma
por: Ragunath, PK, et al.
Publicado: (2012)

Invasive Pleomorphic Lobular Carcinoma of the Breast: Clinicopathologic Characteristics and Prognosis Compared with Invasive Ductal Carcinoma
por: Jung, Seung Pil, et al.
Publicado: (2012)

Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomas
por: Delpech, Y, et al.
Publicado: (2013)

Expression of Sarcosine Metabolism-Related Proteins in Invasive Lobular Carcinoma: Comparison to Invasive Ductal Carcinoma
por: Cha, Yoon Jin, et al.
Publicado: (2015)

Differences in Response and Surgical Management with Neoadjuvant Chemotherapy in Invasive Lobular Versus Ductal Breast Cancer
por: Truin, W., et al.
Publicado: (2015)

Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma
por: Adachi, Yayoi, et al.
Publicado: (2016)

Comparison of Clinicopathological Features and Treatment Results between Invasive Lobular Carcinoma and Ductal Carcinoma of the Breast
por: Park, Jun Su, et al.
Publicado: (2015)

Invasive lobular carcinoma of the breast: A special histological type compared with invasive ductal carcinoma
por: Chen, Zheling, et al.
Publicado: (2017)

Invasive lobular and ductal breast carcinoma differ in immune response, protein translation efficiency and metabolism
por: Du, Tian, et al.
Publicado: (2018)

Histiocytoid breast carcinoma, neither lobular nor ductal? A case report and literature review
por: Ma, Xiao-Li, et al.
Publicado: (2020)

Loss of Mammographic Tissue Homeostasis in Invasive Lobular and Ductal Breast Carcinomas vs. Benign Lesions
por: Gerasimova-Chechkina, Evgeniya, et al.
Publicado: (2021)

Survival Outcomes in Invasive Lobular Carcinoma Compared to Oestrogen Receptor-Positive Invasive Ductal Carcinoma
por: Timbres, Jasmine, et al.
Publicado: (2021)

Classifying invasive lobular carcinoma as special type breast cancer may be reducing its treatment success: A comparison of survival among invasive lobular carcinoma, invasive ductal carcinoma, and no-lobular special type breast cancer
por: Cosar, Rusen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_39cv0516nrtdu3fnvk8dgq4t7e